← back to search

Qing Kay Li

Sidney Kimmel Cancer Center · US
Area of research
Cancer Research · Oncology
Research interest
Research interests include Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, and Immunotherapy and Immune Responses.
h-index
42
citations
12,651
works
218
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗

Recent publications

Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer.
2024cited by 27position: contributordoi
Supplementary Table S7 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
2024cited by 0position: contributordoi
Supplementary Table S11 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
2024cited by 0position: contributordoi
Supplementary Figure S2 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
2024cited by 0position: contributordoi
Supplementary Figure S3 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
2024cited by 0position: contributordoi
Supplementary Table S11 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
2024cited by 0position: contributordoi
Supplementary Figure S9 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
2024cited by 0position: contributordoi
Data from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
2024cited by 0position: contributordoi
Supplementary Table S9 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
2024cited by 0position: contributordoi
Supplementary Table S5 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
2024cited by 0position: contributordoi
Supplementary Table S1 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
2024cited by 0position: contributordoi
Supplementary Table S4 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
2024cited by 0position: contributordoi
Supplementary Figure S7 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
2024cited by 0position: contributordoi
Supplementary Table S5 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
2024cited by 0position: contributordoi
Supplementary Figure S3 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
2024cited by 0position: contributordoi
Supplementary Figure S8 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
2024cited by 0position: contributordoi
Supplementary Figure S2 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
2024cited by 0position: contributordoi
Supplementary Figure S1 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
2024cited by 0position: contributordoi
Supplementary Table S3 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
2024cited by 0position: contributordoi
Supplementary Table S1 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
2024cited by 0position: contributordoi
Supplementary Figure S9 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
2024cited by 0position: contributordoi
Supplementary Table S8 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
2024cited by 0position: contributordoi
Supplementary Table S9 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
2024cited by 0position: contributordoi
Supplementary Table S2 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
2024cited by 0position: contributordoi
Supplementary Table S13 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
2024cited by 0position: contributordoi
Supplementary Table S12 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
2024cited by 0position: contributordoi
Supplementary Figure S4 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
2024cited by 0position: contributordoi
Supplementary Table S10 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
2024cited by 0position: contributordoi
Supplementary Figure S6 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
2024cited by 0position: contributordoi
Supplementary Table S6 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
2024cited by 0position: contributordoi

Grants

Chip-scale quantum spectroscopy for mid-IR gas sensing
NSF2427228$425,0002024–2027PIRePORTER
CADMap: Creating Mapped Solid Models of Deformed As-Manufactured Geometries that Link to an Original Reference Design
NSF2332264$641,8832023–2026PIRePORTER
EAGER: Quantum Manufacturing: Monolithic integration of telecommunication-band quantum emitters in the 4H-SiC-on-insulator platform
NSF2240420$275,0002023–2025PIRePORTER
Collaborative Research: Photonic Chip-Scale Time Crystals
NSF2131162$154,2212022–2025PIRePORTER
Double-layered wide-bandgap photonic materials for efficient nonlinear applications without periodic poling
NSF2127499$395,0002021–2024PIRePORTER

Frequent collaborators

Edward Gabrielson · Johns Hopkins University2 papers (2015–2017)Frederic B. Askin · University of North Carolina at Chapel Hill2 papers (2015–2017)Sonya Parpart-Li · Center for Cancer Research1 papers (2015–2015)Hui Zhang · Qingdao University1 papers (2018–2018)Li Chen · National Yang Ming Chiao Tung University1 papers (2015–2015)Hiroshi Kitagawa · Mie University1 papers (2015–2015)William H. Westra · Moffitt Cancer Center1 papers (2017–2017)Haiying Xu · Bloomberg (United States)1 papers (2015–2015)Peter J. Allen · Duke University1 papers (2015–2015)Siân Jones · Human Genome Sciences (United States)1 papers (2015–2015)Ralph H. Hruban · Occupational Cancer Research Centre1 papers (2015–2015)Victor E. Velculescu · Sidney Kimmel Cancer Center1 papers (2015–2015)Rajni Sharma · Central University of Punjab1 papers (2017–2017)Willie Wilson · Center for Cancer Research1 papers (2015–2015)David S. Klimstra · Marmara University1 papers (2015–2015)Joell J. Gills · Johns Hopkins University1 papers (2015–2015)Rebecca Leary · Novartis (United States)1 papers (2015–2015)Phillip A. Dennis · AVEO Oncology (United States)1 papers (2015–2015)Peter J. O’Dwyer · ECOG-ACRIN Cancer Research Group1 papers (2015–2015)Grzegorz T. Gurda · Johns Hopkins Medicine1 papers (2015–2015)